Immune Infiltration Associated MAN2B1 Is a Novel Prognostic Biomarker for Glioma.

Lin, Xuelei; Liu, Hongwei; Zhao, Hongyu; Xia, Shunjin; Li, Yueshuo; Wang, Chaoqian; Huang, Qi; Wanggou, Siyi; Li, Xuejun

Lin, Xuelei; Liu, Hongwei; Zhao, Hongyu; Xia, Shunjin; Li, Yueshuo; Wang, Chaoqian; Huang, Qi; Wanggou, Siyi; Li, Xuejun.

Afiliación

Lin X; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Liu H; Hunan International Scientific and Technological Cooperation Base of BrainTumor Research, Xiangya Hospital, Central South University, Changsha, China.
Zhao H; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Xia S; Hunan International Scientific and Technological Cooperation Base of BrainTumor Research, Xiangya Hospital, Central South University, Changsha, China.
Li Y; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Wang C; Hunan International Scientific and Technological Cooperation Base of BrainTumor Research, Xiangya Hospital, Central South University, Changsha, China.
Huang Q; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.
Wanggou S; Hunan International Scientific and Technological Cooperation Base of BrainTumor Research, Xiangya Hospital, Central South University, Changsha, China.
Li X; Department of Neurosurgery, Xiangya Hospital, Central South University, Changsha, China.

Front Oncol ; 12: 842973, 2022.

Article en En | MEDLINE | ID: mdl-35186771

Palabras clave

MAN2B1; glioma; immune infiltrates cells; prognosis; tumor-associated macrophage

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google